Pricing
Login
Home
Charts
Search
Watchlist
Products

Valiant Laboratories Ltd

VALIANTLAB
₹94.91-1.99%20 Nov 2026
Reports
Pharma API

Valiant Laboratories Ltd

VALIANTLAB
₹94.91
-1.99%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹515Cr
Close
Close Price
₹94.91
Industry
Industry
Pharma API
PE
Price To Earnings
31.74
PS
Price To Sales
1.37
Revenue
Revenue
₹377Cr
Rev Gr TTM
Revenue Growth TTM
102.38%
PAT Gr TTM
PAT Growth TTM
219.72%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
41311921355847465292115117
Growth YoY
Revenue Growth YoY%
-42.7-66.0-63.3-63.9-13.188.9148.0115.148.959.2146.2152.8
Expenses
ExpensesCr
4735212835544446538786112
Operating Profit
Operating ProfitCr
-6-5-2-71420-15295
OPM
OPM%
-15.6-14.8-12.7-31.41.86.65.10.1-1.75.225.44.4
Other Income
Other IncomeCr
23332-2111010
Interest Expense
Interest ExpenseCr
000000001111
Depreciation
DepreciationCr
011111112334
PBT
PBTCr
-5-30-42120-31261
Tax
TaxCr
-2-101-10104-150
PAT
PATCr
-4-1-1-52120-72210
Growth YoY
PAT Growth YoY%
-145.8-115.8-111.9-700.0167.1156.4456.9104.2-400.4151.41,059.3105.0
NPM
NPM%
-8.6-4.0-2.7-22.16.71.23.90.4-13.51.918.30.3
EPS
EPS₹
-0.8-0.3-0.1-1.00.50.10.40.0-1.30.33.90.1
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
41311921355847465292115117
Growth YoY
Revenue Growth YoY%
-42.7-66.0-63.3-63.9-13.188.9148.0115.148.959.2146.2152.8
Expenses
ExpensesCr
4735212835544446538786112
Operating Profit
Operating ProfitCr
-6-5-2-71420-15295
OPM
OPM%
-15.6-14.8-12.7-31.41.86.65.10.1-1.75.225.44.4
Other Income
Other IncomeCr
23332-2111010
Interest Expense
Interest ExpenseCr
000000001111
Depreciation
DepreciationCr
011111112334
PBT
PBTCr
-5-30-42120-31261
Tax
TaxCr
-2-101-10104-150
PAT
PATCr
-4-1-1-52120-72210
Growth YoY
PAT Growth YoY%
-145.8-115.8-111.9-700.0167.1156.4456.9104.2-400.4151.41,059.3105.0
NPM
NPM%
-8.6-4.0-2.7-22.16.71.23.90.4-13.51.918.30.3
EPS
EPS₹
-0.8-0.3-0.1-1.00.50.10.40.0-1.30.33.90.1

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
334182133237377
Growth
Revenue Growth%
-45.5-26.778.0102.4
Expenses
ExpensesCr
299190138231338
Operating Profit
Operating ProfitCr
35-8-5638
OPM
OPM%
10.5-4.6-3.52.710.2
Other Income
Other IncomeCr
510522
Interest Expense
Interest ExpenseCr
00024
Depreciation
DepreciationCr
222612
PBT
PBTCr
38-1-2125
Tax
TaxCr
9-1149
PAT
PATCr
290-2-316
Growth
PAT Growth%
-98.9-788.7-48.5219.7
NPM
NPM%
8.70.2-1.6-1.44.3
EPS
EPS₹
8.90.1-0.5-0.53.0
Financial YearMar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
334182133237377
Growth
Revenue Growth%
-45.5-26.778.0102.4
Expenses
ExpensesCr
299190138231338
Operating Profit
Operating ProfitCr
35-8-5638
OPM
OPM%
10.5-4.6-3.52.710.2
Other Income
Other IncomeCr
510522
Interest Expense
Interest ExpenseCr
00024
Depreciation
DepreciationCr
222612
PBT
PBTCr
38-1-2125
Tax
TaxCr
9-1149
PAT
PATCr
290-2-316
Growth
PAT Growth%
-98.9-788.7-48.5219.7
NPM
NPM%
8.70.2-1.6-1.44.3
EPS
EPS₹
8.90.1-0.5-0.53.0
Sales CAGR
1 Year78%
3 Years-11%
5 Years-
TTM102%
EBITDA CAGR
1 Year-
3 Years-43%
5 Years-
TTM455%
PAT CAGR
1 Year-
3 Years-
5 Years-
TTM220%
Avg. ROCE
1 Year1%
3 Years0%
5 Years-
TTM8%
CFO / EBITDA
1 Year-163%
3 Years-
5 Years-
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
3343435454
Reserves
ReservesCr
68193191257278
Current Liabilities
Current LiabilitiesCr
51296011996
Non Current Liabilities
Non Current LiabilitiesCr
62771073426
Total Liabilities
Total LiabilitiesCr
213343401464454
Current Assets
Current AssetsCr
151226193228219
Non Current Assets
Non Current AssetsCr
62117208236235
Total Assets
Total AssetsCr
213343401464454
Financial YearMar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
3343435454
Reserves
ReservesCr
68193191257278
Current Liabilities
Current LiabilitiesCr
51296011996
Non Current Liabilities
Non Current LiabilitiesCr
62771073426
Total Liabilities
Total LiabilitiesCr
213343401464454
Current Assets
Current AssetsCr
151226193228219
Non Current Assets
Non Current AssetsCr
62117208236235
Total Assets
Total AssetsCr
213343401464454

Cash Flow

Consolidated
Standalone
Financial YearMar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
5621-10
Investing Cash Flow
Investing Cash FlowCr
-55-144-537
Financing Cash Flow
Financing Cash FlowCr
-1152452
Net Cash Flow
Net Cash FlowCr
010-7-1
Free Cash Flow
Free Cash FlowCr
18-44-112-45
CFO To PAT
CFO To PAT%
193.3589.9-59.7319.2
CFO To EBITDA
CFO To EBITDA%
159.7-22.4-28.1-163.3
Financial YearMar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
5621-10
Investing Cash Flow
Investing Cash FlowCr
-55-144-537
Financing Cash Flow
Financing Cash FlowCr
-1152452
Net Cash Flow
Net Cash FlowCr
010-7-1
Free Cash Flow
Free Cash FlowCr
18-44-112-45
CFO To PAT
CFO To PAT%
193.3589.9-59.7319.2
CFO To EBITDA
CFO To EBITDA%
159.7-22.4-28.1-163.3

Ratios

Consolidated
Standalone
Financial YearMar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
633334279515
Price To Earnings
Price To Earnings
2,080.031.7
Price To Sales
Price To Sales
3.52.51.21.4
Price To Book
Price To Book
2.71.40.91.6
EV To EBITDA
EV To EBITDA
-71.7-81.149.814.3
Profitability Ratios
Profitability Ratios
GPM
GPM%
13.50.05.710.610.6
OPM
OPM%
10.5-4.6-3.52.710.2
NPM
NPM%
8.70.2-1.6-1.44.3
ROCE
ROCE%
23.9-0.2-0.40.87.8
ROE
ROE%
28.90.1-0.9-1.14.9
ROA
ROA%
13.60.1-0.6-0.73.6
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
633334279515
Price To Earnings
Price To Earnings
2,080.031.7
Price To Sales
Price To Sales
3.52.51.21.4
Price To Book
Price To Book
2.71.40.91.6
EV To EBITDA
EV To EBITDA
-71.7-81.149.814.3
Profitability Ratios
Profitability Ratios
GPM
GPM%
13.50.05.710.610.6
OPM
OPM%
10.5-4.6-3.52.710.2
NPM
NPM%
8.70.2-1.6-1.44.3
ROCE
ROCE%
23.9-0.2-0.40.87.8
ROE
ROE%
28.90.1-0.9-1.14.9
ROA
ROA%
13.60.1-0.6-0.73.6
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr1,313795627515487257191
Close PriceClose₹446.1579.28179.3794.911,610.8058.679.81
IndustryIndustryPharma APIPharma APIPharma APIPharma APIPharma APIPharma APIPharma API
Price To EarningsPE25.0216.6211.1331.7437.596.78
Price To SalesPS2.561.020.931.371.460.65109.52
RevenueRevenueCr5137786763773343952
Revenue Growth TTMRev Gr TTM%-8.8%6.6%7.5%102.4%-1.0%-70.8%
PAT Growth TTMPAT Gr TTM%-55.3%23.4%4.8%219.7%-44.7%81.7%
Market CapitalizationMkt CapCr1,313795627515487257191
Close PriceClose₹446.1579.28179.3794.911,610.8058.679.81
IndustryIndustryPharma APIPharma APIPharma APIPharma APIPharma APIPharma APIPharma API
Price To EarningsPE25.0216.6211.1331.7437.596.78
Price To SalesPS2.561.020.931.371.460.65109.52
RevenueRevenueCr5137786763773343952
Revenue Growth TTMRev Gr TTM%-8.8%6.6%7.5%102.4%-1.0%-70.8%
PAT Growth TTMPAT Gr TTM%-55.3%23.4%4.8%219.7%-44.7%81.7%
Annual Reports
FY2026
FY2025
FY2024
Quarterly Reports
FY2026
Sep 26
Result
PPT
Transcript
Summary
Jun 26
Result
PPT
Transcript
Summary
Mar 26
Result
PPT
Transcript
Summary
Dec 25
Result
PPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Jun 25
Result
PPT
Transcript
Summary
Mar 25
Result
PPT
Transcript
Summary
Dec 24
Result
PPT
Transcript
Summary
Sep 24
Result
PPT
Transcript
Summary
Jun 24
Result
PPT
Transcript
Summary
Mar 24
Result
PPT
Transcript
Summary
Dec 23
Result
PPT
Transcript
Summary
Sep 23
Result
PPT
Transcript
Summary
Annual Reports
Quarterly Reports
Sep 26
Result
PPT
Transcript
Summary
Jun 26
Result
PPT
Transcript
Summary
Mar 26
Result
PPT
Transcript
Summary
Dec 25
Result
PPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Jun 25
Result
PPT
Transcript
Summary
Mar 25
Result
PPT
Transcript
Summary
Dec 24
Result
PPT
Transcript
Summary
Sep 24
Result
PPT
Transcript
Summary
Jun 24
Result
PPT
Transcript
Summary
Mar 24
Result
PPT
Transcript
Summary
Dec 23
Result
PPT
Transcript
Summary
Sep 23
Result
PPT
Transcript
Summary
Load More
Interviews